Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12284779 | 0.98 | NAAA (0.34) | NAAACYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL12284800 | 0.92 | NAAA (0.31) | NAAATSHRNPSR1 | |
| SCHEMBL14648997 | 0.91 | NAAA (0.31) | NAAATSHRNPSR1 | |
| SCHEMBL12284651 | 0.91 | TSHR (0.33) | NAAATSHRNPSR1 | |
| SCHEMBL12285391 | 0.90 | TSHR (0.35) | NAAATSHRNPSR1 | |
| SCHEMBL12284653 | 0.89 | — | — | |
| SCHEMBL14648973 | 0.88 | TSHR (0.30) | TSHRNPSR1 | |
| SCHEMBL17668300 | 0.87 | NAAA (0.40) | NAAATSHRNPSR1 | |
| SCHEMBL74710 | 0.87 | NAAA (0.40) | NAAATSHRNPSR1 | |
| SCHEMBL14997755 | 0.87 | NAAA (0.40) | NAAATSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150316847-A1 | HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2015-11-05 | — | — | US | disclosed |
| US-20150316847-A1 | HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2015-11-05 | — | — | US | disclosed |
| US-20130022914-A1 | HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-20130022914-A1 | HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130022914-A1 | HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST | CRY1, HPD, CRY2 | NAAA 2518/4885CYP17A1 372/4885CYP19A1 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.